Key facts
- It has raised $63.5M.
- Notable investors include Gratitude Railroad, NJF Capital, Candide Group, Stardust Equity, Soros Economic Development Fund — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Cadence OTC
- ·The full record, as it builds
Funding rounds
No funding rounds for Cadence OTC are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cadence OTC
Developer of birth control pills designed to assist in the process of unwanted pregnancy. The company's product portfolio includes oral contraceptive pills under an over-the-counter (OTC) status and brings OTC emergency contraceptives to convenience stores without any prescription, helping users with the availability of reproductive health options.
- Sector
- Healthcare
- HQ
- Oakland, CA, United States
- Founded
- 2014
- Employees
- 8
- Website
- cadenceotc.com/
- Ownership
- Privately Held (backing)
Cadence OTC doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cadence OTC shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cadence OTC in its N-PORT filings yet. We sweep new filings monthly.